Hitachi Chemical Co., Ltd. and The University of Texas MD Anderson Cancer Center have entered into a four-year strategic alliance funded by Hitachi to help develop and evaluate the company’s Micro Cavity Array (MCA) Circulating Tumor Cell (CTC) system for the isolation of CTC that can be subjected to downstream molecular analyses.
CTCs offer an alternative to more invasive procedures for assessing tumors, and have proven...
The University of Texas MD Anderson Cancer Center heads to Aspen this summer for its 18th annual Making Cancer History® seminar. The free...
Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice,...
The University of Texas MD Anderson Cancer Center will join institutions across the country in the inaugural national Cancer Moonshot Summit, convened at the request of Vice President Joe Biden, on June 29.
MD Anderson will host a free breakfast event in conjunction with the national summit, which is designed to bring together patients and survivors, researchers, physicians, advocates, philanthropists and data and tech experts...
Early-stage breast cancer patients receiving a shorter course of whole breast radiation with higher radiation doses per fraction reported...
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic...
HOUSTON and NEW YORK -- Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a new clinical...
ABSTRACT: 9004
Lung cancer patients with oligometastases, defined as three or fewer sites of metastasis, may benefit from aggressive...
ABSTRACTS: 5506, 5502, 1506
Advances that could change gynecologic cancer standard–of-care treatments are the centerpiece of...
ABSTRACT: 4501
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder...
ABSTRACT: 3503
In the first-ever clinical trial for metastatic patients previously treated for the disease, research led by The University...
ABSTRACT: 6519
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness...